Marshall Wace LLP trimmed its position in shares of Anterix Inc. (NASDAQ:ATEX - Free Report) by 57.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,519 shares of the company's stock after selling 54,772 shares during the quarter. Marshall Wace LLP owned 0.22% of Anterix worth $1,243,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of ATEX. Barclays PLC lifted its holdings in Anterix by 278.2% in the third quarter. Barclays PLC now owns 16,971 shares of the company's stock valued at $639,000 after acquiring an additional 12,484 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Anterix by 188.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 33,832 shares of the company's stock worth $1,274,000 after purchasing an additional 22,092 shares during the period. Inspire Investing LLC boosted its holdings in shares of Anterix by 19.4% in the fourth quarter. Inspire Investing LLC now owns 13,018 shares of the company's stock worth $399,000 after buying an additional 2,115 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in Anterix by 8,107.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 11,080 shares of the company's stock valued at $333,000 after buying an additional 10,945 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in Anterix by 0.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 134,400 shares of the company's stock valued at $4,122,000 after buying an additional 1,183 shares during the last quarter. 87.67% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, JPMorgan Chase & Co. lifted their price target on shares of Anterix from $61.00 to $67.00 and gave the stock an "overweight" rating in a research note on Thursday, February 13th.
Read Our Latest Stock Analysis on Anterix
Anterix Stock Down 1.0 %
NASDAQ:ATEX traded down $0.29 during mid-day trading on Monday, hitting $29.56. 8,966 shares of the company traded hands, compared to its average volume of 167,668. The stock's fifty day moving average price is $34.88 and its 200-day moving average price is $33.40. The firm has a market cap of $549.34 million, a price-to-earnings ratio of -18.13 and a beta of 0.94. Anterix Inc. has a one year low of $27.37 and a one year high of $42.91.
Anterix Profile
(
Free Report)
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
Further Reading
Before you consider Anterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.
While Anterix currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
